Table 2 Relationship between PCDH8 methylation and clinicopathological characteristics in NMIBC (n = 233)
Features | Variables | No. | M (%) | U (%) | P |
|---|---|---|---|---|---|
Age | 65 | 86 | 46(53.5) | 40(46.5) | 0.7342 |
>65 | 147 | 82(55.8) | 65(44.2) | Â | |
Sex | Male | 161 | 94(58.4) | 67(41.6) | 0.1135 |
Female | 72 | 34(47.2) | 38(52.8) | Â | |
Number | Single | 142 | 82(57.8) | 60(42.2) | 0.2814 |
Multiple | 91 | 46(50.6) | 45(49.4) | Â | |
Size | ≤3 cm | 139 | 69(49.6) | 70(50.4) | 0.0482 |
>3Â cm | 94 | 59(62.8) | 35(37.2) | Â | |
Grade | G1/ G2 | 144 | 67(46.5) | 77(53.5) | 0.0010 |
G3 | 89 | 61(68.5) | 28(31.5) | Â | |
Stage | Ta | 95 | 43(45.3) | 52(54.7) | 0.0138 |
T1 | 138 | 85(61.6) | 53(38.4) | Â | |
Recurrence | No | 127 | 40(31.5) | 87(68.5) | <0.0001 |
Yes | 106 | 88(83.0) | 18(17.0) | Â | |
Progression | No | 175 | 80(45.7) | 95(54.3) | <0.0001 |
Yes | 58 | 48(82.8) | 10(17.2) | Â |